0 Kommentare
0 Anteile
31 Ansichten
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
-
NEUIGKEITEN
- EXPLORE
-
Seiten
-
Gruppen
-
Blogs
-
Foren
-
Please log in to like, share and comment!
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Kommentare 0 Anteile 1KB Ansichten
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Kommentare 0 Anteile 1KB Ansichten
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Kommentare 0 Anteile 1KB Ansichten
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Kommentare 0 Anteile 1KB Ansichten
-
Neurofibromatosis Drugs Market Innovation and Pipeline AnalysisNeurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...0 Kommentare 0 Anteile 394 Ansichten
-
Ovarian Cancer Diagnostics and Therapeutics Market Global Industry OverviewThe global ovarian cancer diagnostics and therapeutics market is witnessing significant growth due to the increasing prevalence of ovarian cancer, rising awareness regarding early detection, and continuous advancements in precision medicine. Healthcare providers and pharmaceutical companies are investing heavily in innovative diagnostic technologies and targeted treatment approaches to improve...0 Kommentare 0 Anteile 412 Ansichten
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Kommentare 0 Anteile 1KB Ansichten
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek